Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A case for geriatric oncology.

Lazzaro Repetto1, Lodovico Balducci

  • 1Istituto Nazionale di Riposo e Cura per Anziani, Rome, Italy.

The Lancet. Oncology
|June 18, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neutropenic events associated with new anticancer treatments, from pathophysiology to practice: a scoping review-NEW Group (Neutropenic Events Working Group).

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025
Same author

Trends in the use of granulocyte colony stimulating factors for older patients with cancer, 2010 to 2019.

Journal of geriatric oncology·2024
Same author

Reflections on Agape and Death.

Journal of palliative medicine·2024
Same author

Love and frailty and an avalanche of missteps.

Journal of the American Geriatrics Society·2024
Same author

Senotherapy, cancer, and aging.

Journal of geriatric oncology·2023
Same author

Resilience in Older Adults Diagnosed With Cancer and Receiving Chemotherapy.

Clinical journal of oncology nursing·2023
Same journal

Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS).

The Lancet. Oncology·2026
Same journal

Differential impact of proton pump inhibitors and antibiotics on immunotherapy efficacy after chemoradiotherapy in locally advanced non-small-cell lung cancer: a post-hoc analysis of the PACIFIC trial.

The Lancet. Oncology·2026
Same journal

Co-medications and gut microbiome in NSCLC immunotherapy.

The Lancet. Oncology·2026
Same journal

Carcinogenicity of butyl benzyl phthalate, dibutyl phthalate, and diisononyl phthalate.

The Lancet. Oncology·2026
Same journal

New report sheds light on cancer disparities in the USA.

The Lancet. Oncology·2026
Same journal

Review highlights gaps in South Africa's cancer care.

The Lancet. Oncology·2026
See all related articles

Cancer incidence rises with age due to prolonged carcinogenesis, molecular changes, and environmental shifts. Tailored geriatric assessments are crucial for effective cancer treatment in older adults.

Area of Science:

  • Geriatric Oncology
  • Cancer Biology
  • Aging Research

Background:

  • Cancer incidence significantly increases with advancing age, a trend amplified by growing global life expectancy.
  • The relationship between aging and cancer is multifaceted, involving extended carcinogenic processes, age-related molecular alterations, and a pro-cancerous shift in the body's environment.
  • The clinical presentation and progression of various cancers can be influenced by age-related changes in both tumor cells and the host's immune system.

Purpose of the Study:

  • To review the complex biological and clinical interactions between cancer and the aging process.
  • To highlight the need for age-specific considerations in cancer diagnosis and treatment.
  • To discuss the essential skills and knowledge required for geriatric oncology care.

Main Methods:

Related Experiment Videos

  • Literature review focusing on the biological mechanisms linking aging and cancer.
  • Analysis of clinical data on age-related variations in cancer behavior and treatment outcomes.
  • Examination of comprehensive geriatric assessment tools for optimizing cancer care in older adults.

Main Results:

  • Aging contributes to cancer development through extended exposure, molecular changes mimicking carcinogenesis, and an aging-associated environment that promotes tumor growth.
  • Cancer's clinical behavior, including response to therapy, can differ in older patients due to intrinsic tumor variations and host factors.
  • Geriatric assessments are vital for tailoring cancer interventions, considering factors like functional status, comorbidities, cognition, and polypharmacy.

Conclusions:

  • The increasing prevalence of cancer in aging populations necessitates a deeper understanding of the cancer-aging nexus.
  • Therapeutic strategies for older cancer patients must balance life expectancy with treatment risks and benefits, informed by comprehensive geriatric evaluations.
  • Further research is needed to address unanswered questions regarding the causes of cancer in the aged, age-related cancer biology, optimal treatment goals, and prevention efficacy.